Positions

Selected Publications

Academic Article

Year Title Altmetric
2021 A randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition in metastatic soft tissue sarcoma.Journal of Clinical Oncology.  39:TPS11583-TPS11583. 2021
2021 Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.Journal of Clinical Oncology.  39:11508-11508. 2021
2020 A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapyEuropean journal of cancer.  137:1-9. 2020
2020 Secondary Sarcomas: Biology, Presentation, and Clinical CareAmerican Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting.  463-474. 2020
2018 Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNSTOncotarget.  9:23018-23028. 2018

Education And Training

  • Doctor of Medicine, Rush University 2015
  • Full Name

  • Vanessa Eulo